Given the confinement of trial evidence to patients with the established indications for use of GLP-1 agonists, howeverpatients either had a BMI of 27 or greater, type 2 diabetes mellitus, or boththe literature remains incomplete
Media headlines vs medical reality Recent headlines have raised concerns about a possible link between GLP-1 medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) and pancreatitis, a potentially serious condition
That is one of the most overlooked challenges of GLP-1 therapy
Grab your copy of the 7-Day GLP-1 Meal Plan and start fueling your body with meals that work with your appetite, not against it
If you have problems with your pancreas, the Mounjaro prescribing doctor needs to know before starting your treatment
Researchers reported that outcomes across the studies suggested a potential association between peptide exposure, ultraviolet interaction, and increased melanin related activity